Related Experiment Videos
Treatment of hepatocellular carcinoma in patients with cirrhosis
1Service d'Hépato-Gastroentérologie, Hôpital Jean Verdier, Bondy, France.
Journal of Hepatology
|November 19, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement.
Alimentary pharmacology & therapeutics·2018
[Results of percutaneous radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis aged 75 years and over].
La Revue de medecine interne·2012
The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.
Clinics and research in hepatology and gastroenterology·2011
HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.
Journal of viral hepatitis·2011
Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis.
Journal of hepatology·2026
Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study.
Journal of hepatology·2026
EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.
Journal of hepatology·2026